BFM
BNTX icon

Boothbay Fund Management’s BioNTech BNTX Stock Holding History

Boothbay Fund Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,800
Closed -$2.67M – 2145
2022
Q4 		$2.67M Buy
+17,800
New +$2.74M 0.06% 477
2022
Q1 		– Sell
-13,500
Closed -$3.48M – 2287
2021
Q4 		$3.48M Buy
+13,500
New +$3.7M 0.08% 299
2021
Q1 		– Sell
-338
Closed -$2.75M – 1549
2020
Q4 		$2.75M Buy
+338
New +$33.2K 0.1% 195

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Boothbay Fund Management's BNTX Position: Q3 2025 in Review

Boothbay Fund Management sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 3,000 shares — an estimated $319K sold.

Boothbay Fund Management first reported a position in BNTX in Q3 2021 and held it in 3 quarters. The position peaked at $2.71M in Q4 2022. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Boothbay Fund Management reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 3,000 BioNTech shares in Q3 2025, an estimated $319K.
  • Boothbay Fund Management first reported a position in BioNTech in Q3 2021 and held it in 3 quarters.
  • Boothbay Fund Management's BioNTech position peaked at $2.71M in Q4 2022.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.